Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-mggfc Total loading time: 0 Render date: 2025-02-25T06:08:12.394Z Has data issue: false hasContentIssue false

Chapter 33 - Cardiovascular System: Pharmacology

Published online by Cambridge University Press:  21 February 2025

By
Edward R Mathney
Edited by
Dharti Patel ,
Sang J. Kim ,
Himani V. Bhatt  and
Alopi M. Patel
Dharti Patel
Affiliation:
Mount Sinai West and Morningside Hospitals, New York
Sang J. Kim
Affiliation:
Hospital for Special Surgery, New York
Himani V. Bhatt
Affiliation:
Mount Sinai West and Morningside Hospitals, New York
Alopi M. Patel
Affiliation:
Rutgers Robert Wood Johnson Medical School, New Jersey
Get access

Summary

The cardiovascular pharmacology chapter focuses on therapeutic agents utilized by anesthesiologists in the treatment of a myriad of pathologies encountered in the operating room environment and elsewhere. The chapter provides a succinct outline of major classes of cardiovascular drugs that are an integral part of the practice of anesthesiology. The aim of the chapter is to deliver said material in an easy to read format to those preparing for board examinations and as a review for the practicing anesthesiology resident physician

Keywords

PharmacologyInotropeVasopressorVasodilatorAnti-arrhythmicPhosphodiesterase InhibitorAnti-anginal agentElectrolytesAngiotensin Converting Enzyme InhibitorBeta blocker
Type
Chapter
Information
BASIC Essentials
A Comprehensive Review for the Anesthesiology BASIC Exam
 , pp. 176 - 185
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Royster, RL, Groban, L, Locke, AQ, Morris, BN, Slaughter, TF. Cardiovascular pharmacology. In Kaplan, JA, Augoustides, JGT, Maneck, GR, Maus, T, Reich, DL, editors. Kaplan’s Cardiac Anesthesia: In Cardiac and Noncardiac Surgery. Elsevier, 2017; pp 292–354.Google Scholar
Zimmerman, J, Cahalan, M. Vasopressors and inotropes. In Hemmings, HC, Egan, TD, editors. Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. Elsevier, 2013; pp 390–404.CrossRefGoogle Scholar
Levy, JH, Ghadimi, K, Bailey, JM, Ramsay, JG. Postoperative cardiovascular management. In Kaplan, JA, Augoustides, JGT, Maneck, GR, Maus, T, Reich, DL, editors. Kaplan’s Cardiac Anesthesia: In Cardiac and Noncardiac Surgery. Elsevier, 2017; pp 1327–1357.Google Scholar
Gold Standard, Inc. Milrinone. Clinical Pharmacology [database online]. Available at: http://clinicalpharmacology.com (accessed August 3, 2017).Google Scholar
Gold Standard, Inc. Sildenafil. Clinical Pharmacology [database online]. Available at: http://clinicalpharmacology.com (accessed August 3, 2017)Google Scholar
Amsterdam, EA, Wenger, NK, Brindis, RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes. Circulation 2014;130(25):e344–e426.Google ScholarPubMed
Tarkin, JM, Kaski, JC. An overview of treatment guidelines: ESC/ACC-AHA/NICE. In Avanzas, P, Kaski, JC, editors. Pharmacological Treatment of Chronic Stable Angina Pectoris Ebook. Springer, 2015; pp 33–56. (overview)CrossRefGoogle Scholar
Carro, A, Avanzas, P. Nitrates. In Avanzas, P, Kaski, JC, editors. Pharmacological Treatment of Chronic Stable Angina Pectoris, ebook. Springer, 2015; pp 87–114.CrossRefGoogle Scholar
Tarkin, JM, Kaski, JC. Nicorandil. In Avanzas, P, Kaski, JC, editors. Pharmacological Treatment of Chronic Stable Angina Pectoris, ebook. Springer, 2015; pp 115–134.CrossRefGoogle Scholar
Dominguez-Rodriguez, A. Ivabradine. In Avanzas, P, Kaski, JC, editors. Pharmacological Treatment of Chronic Stable Angina Pectoris, ebook. Springer, 2015; pp 135–152.CrossRefGoogle Scholar
Rosano GMC, C. Vitale, C, Volterrani, M. Ranolazine. In Avanzas, P, Kaski, JC, editors. Pharmacological Treatment of Chronic Stable Angina Pectoris, ebook. Springer, 2015; pp 173–188.CrossRefGoogle Scholar
Gold Standard, Inc. Ranolazine. Clinical Pharmacology [database online]. Available at: http://clinicalpharmacology.com (accessed August 3, 2017).Google Scholar
Dolinko, AV, Kuntz, MT, Antman, EM, Strichartz, GR, Lilly, LS. Cardiovascular drugs. In Lilly, LS, editor. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Wolters Kluwer, 2016; pp 400–455.Google Scholar
Drago, J, Williams, GH, Lilly, LS. Hypertension. In Lilly, LS, editor. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Wolters Kluwer, 2016; pp 310–333.Google Scholar
Edwards, MR, Grocott, MPW. Perioperative fluid and electrolyte therapy. In Miller, RD, Cohen, NH, Eriksson, LI, et al., editors. Miller’s Anesthesia. Elsevier, 2015; pp 1767–1810.Google Scholar
Freudzon, L, Akhtar, S, London, MJ, Barash, PG. Electrocardiographic monitoring. In Kaplan, JA, Augoustides, JGT, Maneck, GR, Maus, T, Reich, DL, editors. Kaplan’s Cardiac Anesthesia: In Cardiac and Noncardiac Surgery. Elsevier, 2017; pp 357–389.Google Scholar
Hruska, KA, Mathew, S, Lund, R, Qiu, P, Pratt, R. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008;74:148–157.CrossRefGoogle ScholarPubMed
Shiber, JR, Mattu, A. Serum phosphate abnormalities in the emergency department. J Emerg Med 2002;23(4):395–400.CrossRefGoogle ScholarPubMed
Geerse, DA, Bindels, AJ, Kuiper, MA, et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010;14:R147.CrossRefGoogle ScholarPubMed
Kam, PCA, Williams, S, Yoong, FFY. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004;59:993–1001.CrossRefGoogle ScholarPubMed
Currigan, DA, Hughes, RJA, Wright, CE, Angus, JA, Soeding, PF. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries. An in vitro study. Anesthesiology 2014;121:930–936.CrossRefGoogle Scholar
Nguyen, L, Roth, DM, Shanewise, JS, Kaplan, JA. Discontinuing cardiopulmonary bypass. In Kaplan, JA, Augoustides, JGT, Maneck, GR, Maus, T, Reich, DL, editors. Kaplan’s Cardiac Anesthesia: In Cardiac and Noncardiac Surgery. Elsevier, 2017; pp 1291–1310.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×